Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials

被引:31
作者
Ruperto, N
Giannini, EH
机构
[1] UNIV CINCINNATI, CHILDRENS HOSP,COLL MED,MED CTR,DEPT PEDIAT, WILLIAMS S ROWE DIV RHEUMATOL, CINCINNATI, OH 45229 USA
[2] UNIV PAVIA, IRCCS, POLICLIN SAN MATTEO, PEDIAT CLIN, I-27100 PAVIA, ITALY
关键词
D O I
10.1136/ard.55.1.73
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To estimate the degree of redundancy among articular response variables used routinely in juvenile chronic arthritis (JCA) clinical trials. Methods-We obtained data from a large, computerised databank holding information from multiple clinical trials in children with JCA to determine Pearson correlation coefficients for changes from baseline values in articular response variables. All 508 JCA patients who entered the analysis of efficacy of the original trials were included in the present study. An r value of 0.7 or greater was considered evidence of colinearity. Results-When changes in joint counts of articular manifestations were compared with changes in the respective severity scores (for example swollen joint count versus swelling severity score), the r values were always greater than or equal to 0.7. Three articular response variables related to the assessment of pain are all highly correlated with each other. The number of joints with active arthritis was correlated with the number of joints with swelling and the swelling score. Change in the overall severity score was highly correlated (r greater than or equal to 0.7) with change in nearly all articular response variables. Conclusions-Many endpoints reported in JCA trials are redundant, especially counts and scores of the same articular measure. Eliminating redundant variables would provide the same information with less complexity, and decrease the probability of statistical error and ambiguous results.
引用
收藏
页码:73 / 75
页数:3
相关论文
共 12 条
  • [1] WHICH TRADITIONAL MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    ANDERSON, JJ
    FELSON, DT
    MEENAN, RF
    WILLIAMS, HJ
    [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (09): : 1093 - 1099
  • [2] BREWER EJ, 1982, J RHEUMATOL, V9, P109
  • [3] PENICILLAMINE AND HYDROXYCHLOROQUINE IN THE TREATMENT OF SEVERE JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA USSR DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    BREWER, EJ
    GIANNINI, EH
    KUZMINA, N
    ALEKSEEV, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20) : 1269 - 1276
  • [4] FELSON DT, 1993, J RHEUMATOL, V20, P531
  • [5] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    CHERNOFF, M
    FRIED, B
    FURST, D
    GOLDSMITH, C
    KIESZAK, S
    LIGHTFOOT, R
    PAULUS, H
    TUGWELL, P
    WEINBLATT, M
    WIDMARK, R
    WILLIAMS, HJ
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (06): : 729 - 740
  • [6] Giannini Edward H., 1994, Arthritis and Rheumatism, V37, pS428
  • [7] METHOTREXATE IN RESISTANT JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA-USSR DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    GIANNINI, EH
    BREWER, EJ
    KUZMINA, N
    SHAIKOV, A
    MAXIMOV, A
    VORONTSOV, I
    FINK, CW
    NEWMAN, AJ
    CASSIDY, JT
    ZEMEL, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (16) : 1043 - 1049
  • [8] AURANOFIN IN THE TREATMENT OF JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA-USSR DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    GIANNINI, EH
    BREWER, EJ
    KUZMINA, N
    SHAIKOV, A
    WALLIN, B
    [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (04): : 466 - 476
  • [9] GIANNINI EH, 1982, J RHEUMATOL, V9, P114
  • [10] SILVERMAN ED, 1994, J RHEUMATOL, V21, P2353